Damora Therapeutics, Inc (DMRA) insider trading
Every open-market stock purchase and sale by Damora Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Jennifer Jarrett (CEO) bought $253K in the last 90 days.
Last 12 months: insiders bought $253K (1 buy) and sold $7.3K (1 sale). Last close $21.71 on Oct 22, 2026.
Recent DMRA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 25, 2026 | Jennifer Jarrett (CEO) | Bought | $253K |
| Aug 12, 2026 | Andrew Cheng (Insider) | Bought (not open market) | — |
| Jul 6, 2026 | Garrett Winslow (General Counsel) | Sold | $7.3K |
| Jul 3, 2026 | Garrett Winslow (General Counsel) | Bought (not open market) | — |
| Jul 3, 2026 | Garrett Winslow (General Counsel) | Bought (not open market) | — |
| Mar 30, 2026 | Jennifer Jarrett (Insider) | Bought (not open market) | — |
| Mar 30, 2026 | Jennifer Jarrett (Insider) | Bought (not open market) | — |
| Mar 23, 2026 | Michael Landsittel (Insider) | Bought (not open market) | — |
| Mar 23, 2026 | Cameron Turtle (Insider) | Bought (not open market) | — |
| Mar 23, 2026 | Garrett Winslow (General Counsel) | Bought (not open market) | — |
| Mar 23, 2026 | Fairmount Funds Management LLC (Insider) | Bought (not open market) | — |
| Mar 23, 2026 | Julianne Bruno (Insider) | Bought (not open market) | — |
| Mar 23, 2026 | Christopher W. Cain (Insider) | Bought (not open market) | — |
Who's trading DMRA
- Jennifer Jarrett, Insider: bought $253K (1 buy), last Sep 25, 2026
- Andrew Cheng, Insider: other filings, last Aug 12, 2026
- Garrett Winslow, General Counsel: sold $7.3K (1 sale), last Jul 6, 2026
- Fairmount Funds Management LLC, Insider: other filings, last Mar 23, 2026
- Christopher W. Cain, Insider: other filings, last Mar 23, 2026
- Michael Landsittel, Insider: other filings, last Mar 23, 2026
- Cameron Turtle, Insider: other filings, last Mar 23, 2026
- Julianne Bruno, Insider: other filings, last Mar 23, 2026
Get free alerts when an insider at Damora Therapeutics, Inc files a new trade →